We will join the 10th edition of Paris MASH Meeting (September 2024, 5 & 6) to support rapid diffusion of acquired knowledge in the field of MASH. Thus, we will present our discovery about the antifibrotic effects of our positive allosteric modulators of the GABAA receptor and AI-designed analogs including extended findings. We are looking forward to join interesting talks and discuss about the latest updates on drug development for MASH. Do not hesitate to contact us and meet us there.